home / stock / juno / juno quote
Last: | $ |
---|---|
Change Percent: | 0.02% |
Open: | $86.62 |
Close: | $86.60 |
High: | $86.63 |
Low: | $86.56 |
Volume: | 5,355,348 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $86.62 | $86.60 | $86.63 | $86.56 | 5,355,348 | 02-26-2018 |
$ | $86.59 | $86.58 | $86.59 | $86.55 | 4,297,461 | 02-23-2018 |
$ | $86.65 | $86.56 | $86.68 | $86.56 | 5,445,841 | 02-22-2018 |
$ | $86.74 | $86.64 | $86.76 | $86.57 | 10,954,446 | 02-21-2018 |
$ | $85.15 | $84.98 | $85.39 | $84.77 | 3,246,987 | 02-20-2018 |
$ | $85.40 | $85.10 | $85.48 | $85.10 | 3,052,715 | 02-16-2018 |
$ | $85.82 | $85.45 | $85.93 | $85.38 | 4,048,297 | 02-15-2018 |
$ | $85.90 | $85.82 | $86.16 | $85.80 | 2,180,642 | 02-14-2018 |
$ | $85.76 | $86.08 | $86.20 | $85.75 | 2,153,155 | 02-13-2018 |
$ | $85.55 | $85.84 | $85.95 | $85.53 | 2,971,635 | 02-12-2018 |
$ | $85.76 | $85.69 | $85.92 | $85.57 | 5,799,663 | 02-09-2018 |
$ | $85.77 | $85.55 | $86.08 | $85.55 | 4,193,777 | 02-08-2018 |
$ | $85.45 | $85.90 | $85.96 | $85.43 | 4,269,387 | 02-07-2018 |
$ | $85.52 | $85.49 | $85.87 | $85.27 | 6,155,181 | 02-06-2018 |
$ | $85.54 | $85.62 | $86.15 | $85.54 | 5,816,806 | 02-05-2018 |
$ | $85.70 | $85.60 | $85.87 | $85.60 | 6,609,487 | 02-02-2018 |
$ | $85.78 | $85.57 | $85.871 | $85.50 | 6,010,538 | 02-01-2018 |
$ | $85.70 | $85.81 | $85.96 | $85.63 | 3,843,105 | 01-31-2018 |
$ | $85.50 | $85.74 | $85.90 | $85.45 | 5,613,352 | 01-30-2018 |
$ | $85.70 | $85.56 | $85.74 | $85.45 | 6,594,187 | 01-29-2018 |
News, Short Squeeze, Breakout and More Instantly...
Juno Therapeutics Inc. Company Name:
JUNO Stock Symbol:
NASDAQ Market:
Juno Therapeutics Inc. Website:
June 16 (UPI) -- The 100-plus carat Juno diamond was auctioned Thursday in New York by Sotheby's, bringing in over $12.9 million. The Earth Star, an orange-brown diamond of 111.59 carats, was expected to bring as much as $2.5 million. The Juno diamond is a 101.41 carat pear-shap...
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributor Brian Orelli analyzes Gilead 's (NASDAQ: GILD) earnings report and discusses why the biotech giant could see fairly low revenue growth or even see earnings dr...